Agile Sciences Issued Second U.S. Patent for Compounds that Disperse Biofilms

Share Article

Second US patent expands Agile Sciences' proprietary compound library.

Agile Sciences announced today that the company has received notice that its second licensed patent has been approved by the U.S. Patent and Trademark Office. Entitled "Inhibition of Bacterial Biofilms with Imidazole Derivatives", U.S Patent No. 7,906,544 was issued on March 15, 2011. The company is focused on commercializing technologies that inhibit and disperse biofilms, and the patent covers the composition and use of compounds exclusively licensed by Agile Sciences from North Carolina State University.

"This second patent significantly expands our core intellectual property foundation and should prove quite valuable as we surround that position with additional composition of matter and field of use claims," commented Dr. Christian Melander, co-founder of Agile Sciences.

About Agile Sciences:
Agile Sciences is headquartered on North Carolina State University's Centennial Campus. The company was founded in 2007 by Professors Christian Melander and John Cavanagh of North Carolina State University (NCSU) to provide commercial solutions to those industries plagued by the effects of biofilms. The company's proprietary compounds are derived from the Agelas conifera sea sponge and have been shown to be effective in dispersing biofilms. For additional information, please visit:

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Keith Stoneback
Visit website